Filing Details
- Accession Number:
- 0001437749-16-025977
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-02-24 20:03:13
- Reporting Period:
- 2016-02-22
- Filing Date:
- 2016-02-24
- Accepted Time:
- 2016-02-24 20:03:13
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1178104 | Cardica Inc | CRDC | Surgical & Medical Instruments & Apparatus (3841) | 943287832 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1661542 | A. Michael Bates | 900 Saginaw Drive Redwood City CA 94063 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-02-22 | 2,000 | $2.62 | 23,000 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2016-02-23 | 5,000 | $2.63 | 28,000 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2016-02-24 | 26,600 | $2.99 | 54,600 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is the weighted average price. These shares were bought in multiple transactions at prices ranging from $2.57 to $2.67, inclusive. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares purchased at each separate price within the range set forth in footnote one (1) of this Form 4.
- The price reported in Column 4 is the weighted average price. These shares were bought in multiple transactions at prices ranging from $2.74 to $3.08, inclusive. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares purchased at each separate price within the range set forth in footnote two (2) of this Form 4.